Cargando…
Optimal 2-[(18)F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma
BACKGROUND: Positron emission tomography (PET) with the liver-specific galactose tracer 2-[(18)F]fluoro-2-deoxy-d-galactose ((18)F-FDGal) may improve diagnosis of hepatocellular carcinoma (HCC). The aim of this study was to test which of three different (18)F-FDGal PET protocols gives the highest tu...
Autores principales: | Horsager, Jacob, Bak-Fredslund, Kirstine, Larsen, Lars Peter, Villadsen, Gerda Elisabeth, Bogsrud, Trond Velde, Sørensen, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920802/ https://www.ncbi.nlm.nih.gov/pubmed/27341819 http://dx.doi.org/10.1186/s13550-016-0206-7 |
Ejemplares similares
-
Metabolic liver function in humans measured by 2-(18)F-fluoro-2-deoxy-D-galactose PET/CT–reproducibility and clinical potential
por: Bak-Fredslund, Kirstine P., et al.
Publicado: (2017) -
6-Deoxy-6-fluoro-d-galactose
por: Jenkinson, Sarah F., et al.
Publicado: (2010) -
[(18)F]2-Fluoro-2-deoxy-d-glucose PET/CT in mediastinal masses
por: Rankin, S.
Publicado: (2010) -
2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease
por: Plöckinger, U., et al.
Publicado: (2018) -
Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer
por: Bach-Gansmo, Tore, et al.
Publicado: (2022)